Product Information
QC ASPIRIN EC 81 MG TABLET is a generic product labeled by Chain Drug Marketing Association, priced at $0.0145 per EA under NDC 83324008905. Its NADAC has been published 74 times since Jan 29, 2025.
Strength
81 mg/1
Manufacturer
Chain Drug Marketing AssociationNDC
83324008905
Classification
Generic
Dosage Form
TABLET, DELAYED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ASPIRINApproval Type
OTC MONOGRAPH DRUG
FDA Application
M013On Market Since
5/1/2024
Pharmacological Classes
Price Statistics
The NADAC for QC ASPIRIN EC 81 MG TABLET has been published 74 times since Jan 29, 2025, and over the history we have for it it has risen 6.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0145 per EA |
|---|---|
| All-time high | $0.0155 (Apr 16, 2025) |
| All-time low | $0.0137 (Jan 29, 2025) |
| 52-week high | $0.0149 |
| 52-week low | $0.0142 |
| Median price | $0.0146 |
| Average price | $0.0147 |
| Largest weekly change | +7.7% (Feb 19, 2025) |
| Weeks tracked | 74 |
| Tracking since | Jan 29, 2025 |
Generic Alternatives
The matcher finds 4 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 4 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of QC ASPIRIN EC 81 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for QC ASPIRIN EC 81 MG TABLET, manufactured by Chain Drug Marketing Association, is $0.0145 per EA (NDC 83324008905), effective Jun 24, 2026.
How has the price of QC ASPIRIN EC 81 MG TABLET changed over time?
Over the history we have for it, the NADAC for QC ASPIRIN EC 81 MG TABLET has risen 6.2%. It has been tracked across 74 weekly CMS publications since Jan 29, 2025.
What are the highest and lowest recorded NADAC prices for QC ASPIRIN EC 81 MG TABLET?
Since Jan 29, 2025, the NADAC for QC ASPIRIN EC 81 MG TABLET has ranged from a low of $0.0137 (Jan 29, 2025) to a high of $0.0155 (Apr 16, 2025), with a median of $0.0146 per EA.
Are there cheaper alternatives to QC ASPIRIN EC 81 MG TABLET?
4 NADAC-published products share the same active ingredient, strength, and dosage form as QC ASPIRIN EC 81 MG TABLET, but none are currently priced below it.
Who manufactures QC ASPIRIN EC 81 MG TABLET?
QC ASPIRIN EC 81 MG TABLET (NDC 83324008905) is labeled by Chain Drug Marketing Association, and CMS classifies it as a generic product.
Related Drugs
Same classification